Aortic Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines -

Similar documents
Aortic regurgitation and aneurysm. epidemiology and guidelines

3D- and Multidimensional Echocardiography in Aortic Valve Repair

Aortic Regurgitation & Aorta Evaluation

Surgical indications in ascending aorta aneurysms: What do we know? Jean-Luc MONIN, MD, PhD. Institut Mutualiste Montsouris, Paris, FRANCE

What are the best diagnostic tools to quantify aortic regurgitation?

Echocardiography. Guidelines for Valve and Chamber Quantification. In partnership with

Disclosures. ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech

ASE Guidelines on Aortic Regurgitation What Do I Measure? Case Studies

S. Bruce Greenberg, MD FNASCI and President, NASCI Professor of Radiology and Pediatrics University of Arkansas for Medical Sciences

Affecting the elderly Requiring new approaches. Echocardiographic Evaluation of Hemodynamic Severity. Increasing prevalence Mostly degenerative

Organic mitral regurgitation

LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital

Disclosures Rebecca T. Hahn, MD, FASE

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Valvular Regurgitation: Can We Do Better Than Colour Doppler?

New ASE Guidelines: What you must know

Hemodynamic Assessment. Assessment of Systolic Function Doppler Hemodynamics

Adult Echocardiography Examination Content Outline

How to assess ischaemic MR?

Quantitation of Aortic Regurgitation ASCeXAM / ReASCE Review Course

Aortic regurgitation. Physiopathology. Dr Pilar Tornos Hospital Vall d Hebron. Barcelona Eurovalve 2014

ECHOCARDIOGRAPHY DATA REPORT FORM

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction

The Doppler Examination. Katie Twomley, MD Wake Forest Baptist Health - Lexington

Aortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants

LUST trial. Echocardiography USER S MANUAL

Echocardiography: Guidelines for Valve Quantification

NEW GUIDELINES. A Guideline Protocol for the Assessment of Aortic Regurgitation From the British Society of Echocardiography Education Committee

Severe left ventricular dysfunction and valvular heart disease: should we operate?

The Ross Procedure: Outcomes at 20 Years

What Are the Current Guidelines for Treating Thoracic Aortic Disease?

Spotlight on Valvular Heart Disease Guidelines

Imaging Assessment of Aortic Stenosis/Aortic Regurgitation

PROSTHETIC VALVE BOARD REVIEW

Bogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun

Mitral Valve Disease, When to Intervene

Primary Mitral Regurgitation

Echocardiographic Cardiovascular Risk Stratification: Beyond Ejection Fraction

Sports Participation in Patients with Inherited Diseases of the Aorta

The Bicuspid Aortic Valve: New Frontiers in Genetics and Interventions

MITRAL REGURGITATION ECHO PARAMETERS TOOL

Regurgitant Lesions. Bicol Hospital, Legazpi City, Philippines July Gregg S. Pressman MD, FACC, FASE Einstein Medical Center Philadelphia, USA

Operate NOT every BAV aorta at 5 cm. Markus Schwerzmann, MD

Chamber Quantitation Guidelines: What is New?

New murmur: acute valvular regurgitations. A.Pasquet, MD,PhD. UCL -Cliniques Saint Luc

cardiac imaging planes planning basic cardiac & aortic views for MR

Ascending aorta dilation and aortic valve disease : mechanism and progression

Echocardiographic evaluation of mitral stenosis

Comments restricted to Sapien and Corevalve 9/12/2016. Disclosures: Core Lab contracts with Edwards Lifesciences, Middlepeak, Medtronic

Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention

Imaging in TAVI. Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands Davos, feb 2013

New Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor. Cardiothoracic Radiology

Quantification of Aortic Regurgitation

Comprehensive Echo Assessment of Aortic Stenosis

Bicuspid Aortic Valve: Only Valvular Disease? Artur Evangelista

Gender Differences in Valvular Heart Disease. Linda D. Gillam, MD FESC Disclosure: Core Lab services Edwards Lifesciences

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

The Changing Epidemiology of Valvular Heart Disease: Implications for Interventional Treatment Alternatives. Martin B. Leon, MD

Congenital. Unicuspid Bicuspid Quadricuspid

Quantifying Aortic Regurgitation

TAVR: Echo Measurements Pre, Post And Intra Procedure

When Does 3D Echo Make A Difference?

Mixed aortic valve disease

What echo measurements are key prior to MitraClip?

: mm 86 mm EF mm

Echocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016

Appendix II: ECHOCARDIOGRAPHY ANALYSIS

Tricuspid and Pulmonary Valve Disease

Cover Page. The handle holds various files of this Leiden University dissertation.

Unusual Causes of Aortic Regurgitation. Case 1

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision

THE LEFT ATRIUM HOW CAN ECHO HELP US?

«Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer

Restrictive Cardiomyopathy

Quantitation of right ventricular dimensions and function

Valvular Heart Disease

Assessing the Impact on the Right Ventricle

좌심실수축기능평가 Cardiac Function

Management of Difficult Aortic Root, Old and New solutions

BICUSPID AORTIC VALVE. Surgery everytime over 50 mm

HIGHLIGHT SESSION. Imaging. J. L. Zamorano Gomez (Madrid, ES) Disclosures: Speaker Philips

Outline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II

Ventricular Interactions in the Normal and Failing Heart

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.

Management of significant asymptomatic aortic stenosis. Alec Vahanian Bichat Hospital University Paris VII Paris, France

Advanced Applica,on of Point- of- Care Echocardiography in Cri,cal Care. Dr. Mark Tutschka Dr. Rob ArnAield

Tricuspid and Pulmonary Valve Disease

Prof. JL Zamorano Hospital Universitario Ramón y Cajal

Multi-imaging modality approach. Covadonga Fernández-Golfín Cardiac Imaging Unit. Cardiology Department. Ramón y Cajal Hospital.

PISA Evaluation of Mitral Regurgitation. Raymond Graber, MD Cardiac Anesthesia Group University Hospitals Case Medical Center 4/07/2011

Functional anatomy of the aortic root. ΔΡΟΣΟΣ ΓΕΩΡΓΙΟΣ Διεσθσνηής Καρδιοθωρακοτειροσργικής Κλινικής Γ.Ν. «Γ. Παπανικολάοσ» Θεζζαλονίκη

British Society of Echocardiography

Titel Kardiologie-SG.ch hot topics in heart failure and mitral regurgitation

Pathophysiology: Heart Failure

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.

Stress Testing in Valvular Disease

Transcription:

Reconstruction of the Aortic Valve and Root - A Practical Approach - Aortic Regurgitation and Aortic Aneurysm Wednesday 14 th September - 9.45 Practice must always be founded on sound theory. Leonardo Da Vinci Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 1

Reconstruction of the Aortic Valve and Root - A Practical Approach - I declare for the last 3 years and the subsequent 12 month the following conflicts of interests: Section I: Support for Research Activities - grant of the DEGUM - no other financial research support Section II: Support for Educational Activities - MIFO, GE Healthcare, Astra Zeneca, Servier, Novartis, Berlin-Chemie, Pfizer, Cardiac Dimension, Abbott, Bayer, Kelcon Section III: Honorarium for Promotional Activities - none Section IV: Personal Financial Interests in Vommercial Activities - none IB1; 2A11 Member of the German Society of Cardiology, The German Society of Ultrasound, the German Society of Internal Medicine and the European Society of Cardiology/Cardiovascular Imaging Councillor of the EACVI Board Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 2

The Euro Heart Survey on Valvular Heart Disease included prospectively 5001 patients. according to Iung et al., EurHeartJ 2003:24, 1231-1243 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 3

Incidence in epidemiology is a measure of the probability of occurrence of a given medical condition in a population within a specified period of time. The cumulative incidence is the number of new cases within a specified time period divided by the size of the population initially at risk, e.g cases per 100.000 persons per year. Prevalence is the proportion of cases in the population at a given time usually expressed as a fraction, as a percentage or as the number of cases per 10.000 or 100.000 people. Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 4

Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 5

Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 6

Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 7

And the grading of the severity of VHD seems to be a real problem. Thus, the Euro Heart Survey contains interesting data on characteristics and management of patients with valvular heart disease, but no epidemiological data concerning incidence and prevalence of VHD. Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 8

Echocardiographic characterisation of patients with the ultrasound technique of the nineties. Technology of 2015 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 9

according to Singh et al., Am J Cardiol 1999;83:897-902 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 10

according to Singh et al., Am J Cardiol 1999;83:897-902 This study sought to assess the prevalence and clinical determinants of mitral (MR), tricuspid (TR), and aortic (AR) regurgitation in a population-based cohort. Color Doppler echocardiography was performed in 1696 men and 1893 women (aged 54 6 10 years) attending a routine examination at the Framingham Study. Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 11

according to Singh et al., Am J Cardiol 1999;83:897-902 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 12

Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 13

Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 14

according to Lebowitz et al., J Am Coll Cardiol 2000; 36: 461-467 3D-TTE of the aortic valve Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 15

Frequency or prevalence of aortic regurgitation is about 0.5% of the adult population. Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 16

About 5% for both, AS and AR according to Nkomo et al., Lancet 2006;368: 1005-1012 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 17

Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 18

Survival in pts with severe AR depends on symptons and NYHA classification Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 19

according to Dujardin et al., Ciculation 1999; 99: 1851-1857 Survival is higher, if LVS-diameter/BSA is < 25mm/m 2 If AR is severe, event rate is high. Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 20

according to Dujardin et al., Ciculation 1999; 99: 1851-1857 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 21

Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 22

Reduced LVEF in chronic severe AR is a significant factor of bad prognosis. However, reduced LVEF is not a contraindication to consider AVR. according to Chaliki et al., Circulation 2002;106:2687-2693 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 23

ARincidence: 0.8% Combined AR- and MR- Incidence: 0.5% AR is associated with aortic root diameter- according to Reid et al.; Am J Cardiol 2007;99:830-834 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 24

Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 25

according to Vahanian et al., Eur Heart J 2012; 33: 2451-2496 Symptoms Endsystolic LV-dimension > 50mm LV-ejection fraction < 50% Diastolic LV-Dimension > 70mm Significant progression of symptoms Significant deterioration of indices Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 26

according to Vahanian et al., Eur Heart J 2012; 33: 2451-2496 Conclusion: Grading of the AR severity is the crucial point. Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 27

La Place law: T = ½ P r / d T = wall tension P = transmural pressure r = radius d = wall thickness T r The increase in r compensates volume overload. T r Because wall thickness (also = wall stress) increases, wall tension will be normalized. Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 28

250 225 200 175 150 pressure [mmhg] Aortic Regurgitation and Aortic Aneurysm Pathophysiology of Aortic Regurgitation End-systolic pressure volume relationship (ESPVR) describes the maximal pressure that can be developed by the ventricle at any given LV volume. ESPVR Stroke volume End-diastolic pressure volume relationship (EDPVR) describes the passive filling curve for the ventricle and thus the passive properties of the myocardium. 125 100 75 50 25 Stroke volume Normal conditions Chronic aortic regurgitation volume [ml] EDPVR 50 100 150 200 250 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 29

Chronic Aortic regurgitation Progressive myocardial dysfunction is due to: 1. Impaired myocardial function With an increase of functionally abnormal myocytes and fibrosis 2. Decreased coronary flow reserve Secondary to excentric left ventricular hypertrophy and increased wall stress Patients become symptomatic at different levels of left ventricular dysfunction. But: how to be sure that symptoms are really related to aortic regurgitation? Thus, grading of the aortic regurgitation is the crucial point. Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 30

according to Maurer, Heart 2006;92: 994-1000 Which method for which approach? Semiquantitative: Vena contracta Ratio D jet width /D LVOT Reverse diastolic flow PHT Flow convergence Quantitative: Regurgitant volume by PISA Stroke volumes using PW Doppler at the level of LVOT, MV (total) or PV (effective) Total stroke volume by biplane planimetry later Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 31

Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 32

AR and Aortic Aneurysm Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 33

according to Liddicoat et al., Circulation Suppl 1 1975; 51/52 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 34

according to Nienaber, Eur Heart J 2013; 14: 15-23 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 35

Results about the incidence of TAA Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 36

10% 60% 40% Patterns of involvement of the thoracic aneurysms 10% Incidences: : Aneurysma of the ascending aorta 10 per 100.000 per year m/f = 1.7/1 Aneurysma of the descending aorta 3 per 100.000 per year m/f = 4.1/1 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 37

according to Goldstein et al., J Am Soc Echocardiogr 2015; 28: 119-182 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 38

Assessment of AA includes etiology of AA. according to Goldstein et al., J Am Soc Echocardiogr 2015; 28: 119-182 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 39

Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 40

2096 hypertensive participants 361 normotensive participants > 55mm in no risk pats Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 41

Aortic root dilatation of the sinuses is correlated with Calcified AV Left ventricular motion abnormalities male gender AR is correlated with Calcified AV Aortic root diameter Female gender according to Palmieri et al., Hypertension 2001;37:1229-1235 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 42

Incidence of thoracic aortic disease: 16.3 per 100.000 per year in men and 9.1 per 100.000 per year in women Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 43

Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 44

according to Saura et al., Eur Heart J Cardiovasc Img 2016 doi:10.1093/ehjci/jew053 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 45

according to Saura et al., Eur Heart J Cardiovasc Img 2016 doi:10.1093/ehjci/ jew053 Discussion about echocardiographic measurements of the aortic dimensions: leading-edgeto-leading edge or inner-edge-to inner-edge Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 46

If your image is correct, inner-edge-to-inner edge is correct. according to Saura et al., Eur Heart J Cardiovasc Img 2016 - doi:10.1093/ehjci/jew053 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 47

Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 48

according to Evangelista et al., Eur J Echocardiography 2010; 11: 645-658 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 49

according to Evangelista et al., Eur J Echocardiography 2010; 11: 645-658 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 50

according to Evangelista et al., Eur J Echocardiography 2010; 11: 645-658 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 51

Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 52

according to Goldstein et al., J Am Soc Echocardiogr 2015; 28: 119-182 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 53

according to Goldstein et al., J Am Soc Echocardiogr 2015; 28: 119-182 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 54

Measurements of the Aortic Root: during diastole or duringf systole? In the actual recommendation (EACVI 2010 and 2013) measurements should be performed during systole dimensions are larger during systole than during diastole according to Goldstein et al., J Am Soc Echocardiogr 2015; 28: 119-182 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 55

Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 56

Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 57

according to Mahadevia et al., Circulation 2014; 129:673-682 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 58

according to Mahadevia et al., Circulation 2014; 129:673-682 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 59

Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 60

according to Verma and Siu, N Engl J Med 2014; 370:1920-1928 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 61

according to Vahanian et al., Eur Heart J 2012; 33: 2451-2496 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 62

according to Detaint et al., Heart 2010; 100: 126-134 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 63

Follow Up: 3.6 years±1.2 Dilatation rate: BAV: Marfan: Degenerative: 353 pts 0.42mm/year 50 pts 0.49mm/year 51 pts 0.20mm/year according to Detaint et al., Heart 2010; 100: 126-134 Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 64

Echocardiographic diagnostics: Impact on prevention of TAA rupture Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 65

Summary: AR - Epidemiology and Guidelines Epidemiological data about incidence and prevalence of aortic regurgitation are rare. The prevalence and incidence of aortic regurgitation is age-dependent. The qualitative evidence of aortic regurgitation is about 5% of the total population. The prevalence of severe aortic regurgitation is about 0.5% of the total population. In the elderly > 75 years it is about 5%. Indications for surgery in patients with aortic regurgitation are primarily symptoms, enlargement of LV-dimensions and impairment of LV-function as well as progression of symptoms and deterioration of LV-indices. Impaired LV-function in pts with AR is a significant risk factor of surgical therapy. Symptoms have to be identified in relation to the valvular defect. Thus, the grading of the severity of AR is the crucial factor for the therapeutical decision making. Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 66

Summary: TAA - Epidemiology and Guidelines Epidemiological data about incidence and prevalence of thoracic aortic aneurysms (TAA) are rare. The incidence of aortic regurgitation is about 10 per 100.000 per year. There are various shapes of aortic root and thoracic aortic aneurysms, which have been classified due to different mechanisms. Aortic root aneurysm is related to calcified aortic valves, left ventricular wall motion abnormalities and male gender. The normal values for the aortic root and the proximal thoracic aorta are recently published in the NORRE study. Indications for surgery in patients with TAA are aortic diameter > 45mm in pts with Marfan syndrome, > 50mm in BAV pts with risk factors and > 55mm in allother patients. In BAV pts cusp fusion morphology alters outflow patterns and consecutive aortopathy due to different wall shear-stress TAA has to be monitored to detect aortic enlargement and to prevent aortic dissection. Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 67

Thank You for Your Attention Universitätsmedizin Leipzig (2016) - Hagendorff -Aortic Valve Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines 68